MECHANICAL CIRCULATORY SUPPORT - ADULT (MCS) -> MCS - Complications Bleeding/Thrombosis Abstracts

1002 - Use of Thalidomide for Refractory GI Bleeding in Patients with Continuous Flow Left Ventricular Assist Device (cfLVAD) - The Western Australian (WA) Experience

Presentation Number
1002
Speakers
Session Name
POSTER SESSION 2 - POSTER SESSION: Mechanical Circulatory Support - Adult
Date
Thu, Apr 23, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
999 - Outcomes Following Discontinuation of Warfarin in Heartmate 3 Patients: A Multi-Center Review

Next ePresentations
1003 - The Cause of the Bleeding and Thrombosis in Patients with Implanted Left Ventricular Assist Devices
1005 - Impact of Gastrointestinal Bleeding Burden with Subsequent Outcomes after Left Ventricular Assist Device Implant
1007 - Explantation of Left Ventricular Assist Device as Bridge Therapy is Associated with Diaphragm Dysfunction after Heart Transplantation
1008 - The Cost and Length of Stay Associated with Biventricular Assist Devices in the United States (2009-2015)
1010 - Inflow or Outflow Obstruction Requiring Surgical Corrections Late after HeartMate 3 Left Ventricular Assist Device Insertion
1011 - Persistent Mitral Regurgitation after Left Ventricular Assist Device: A Clinical Conundrum
1013 - Maximum Vasoactive Inotropic Score in the 48 Hours Post-LVAD Implantation Correlates with Early Severe Right Ventricular Failure
1014 - The Effect of Percutaneous Left Ventricular Assist Device Placement to the Native Aortic Valve Competency
1015 - EUROMACS-RHF Risk Score and 3D Echocardiography as Predictors of Right Heart Failure after Left Ventricular Assist Device Implantation
1018 - Incidence and Cause of Persistent Low Flow Alarm after HeartMate 3 Left Ventricular Assist Device Insertion